Skip to main content

Grafton Capital Hires Simon Rowan As Partner

Technology-focused private equity firm Grafton Capital has appointed Simon Rowan as a Partner. Rowan joins Grafton Capital from Dunedin LLP, where he was a Partner and member of the Investment Committee which oversaw the Dunedin Buyout Fund III, which was focused on tech-enabled businesses.

Rowan led the technology enabled services investment team at Dunedin and sat on the Board of Incremental Group, a digital transformation specialist. Prior to Dunedin, he worked in New York in HSBC Investments' fund of funds team before helping to establish HSBC UK Private Equity from London. He has significant investor NXD experience which has encompassed organic and acquisitive growth strategies, international expansion, technology investment, management strengthening and exit planning. Rowan is currently a board advisor to an award winning and highly disruptive EdTech business.

Ed Barroll Brown, Managing Partner of Grafton Capital, said: “We’re delighted to welcome Simon to Grafton Capital. He brings an outstanding personal investment track record, as well as an excellent reputation, having played an important role in Dunedin’s successful Fund III.”

Commenting on his new role, Rowan said: “I have long admired Grafton Capital’s differentiated approach to growth capital investing, and am excited to join their impressive team. Grafton Capital has earned a strong reputation amongst the tech founders it partners with, and I am looking forward to playing my part in the next phase of Grafton Capital’s own growth.”

Founded in 2014, Grafton Capital has invested over £100mn in business and enterprise software companies. It typically invests £5 - £20mn in categories including software, data and analytics, online platforms or marketplaces. In its most recent investment, in July 2021, Grafton Capital invested €18mn in Xtremepush, a software business providing a multi-channel engagement platform to businesses globally.


© The Sortino Group Ltd

All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or scanning or otherwise, except under the terms of the Copyright, Designs and Patents Act 1988 or under the terms of a licence issued by the Copyright Licensing Agency or other Reprographic Rights Organisation, without the written permission of the publisher. For more information about reprints from AlphaWeek, click here.